Co-chair of Oxford University’s production of a vaccine against the disease Covid-19 The chance of success of this experiment does not exceed fifty percent because the Corona virus seems to be fading fast in Britain.
Adrian Hill, director of Oxford University’s Jenner Institute, who collaborated with AstraZeneca, the pharmaceutical maker, to develop the vaccine, said a future trial of 10,000 volunteers was not expected to result in a decline in Covid-19 transmission in society.
“It is a race against the disappearance of the virus and a race against time,” Hill told the Telegraph newspaper. “At this moment, there is a 50 percent chance that we will not achieve a result at all.”
This experimental vaccine is among the leading vaccines in the global race to provide protection against the emerging corona virus.
The Hill team began the first stages of human trials of the vaccine in April.